Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Raquel Martin-AlonsoDepartment of Obstetrics and Gynecology, Hospital Universitario de Torrejón, 28850 Torrejón de Ardoz, Madrid, Spain.ORCID 0000-0003-1075-3789
Catalina de Paco MatallanaSpanish Network in Maternal, Neonatal, Child and Developmental Health Research (RICORS-SAMID, RD24/0013/0018), Instituto de Salud Carlos III, 28040 Madrid, Spain.
Nuria ValiñoSpanish Network in Maternal, Neonatal, Child and Developmental Health Research (RICORS-SAMID, RD24/0013/0018), Instituto de Salud Carlos III, 28040 Madrid, Spain.ORCID 0000-0001-5711-498X
Themistoklis DagklisThird Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-2863-5839
Antonios SiargkasThird Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0003-3066-9963
Alan WrightInstitute of Health Research, University of Exeter, Exeter EX4 4QJ, UK.
Mario CamachoFacultad de Estudios Estadísticos, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0009-0000-2775-2139
Valeria RolleDepartment of Obstetrics and Gynecology, Hospital Universitario de Torrejón, 28850 Torrejón de Ardoz, Madrid, Spain.ORCID 0000-0002-1793-7049
Belén SantacruzDepartment of Obstetrics and Gynecology, Hospital Universitario de Torrejón, 28850 Torrejón de Ardoz, Madrid, Spain.ORCID 0000-0003-1817-3092
Maria M GilDepartment of Obstetrics and Gynecology, Hospital Universitario de Torrejón, 28850 Torrejón de Ardoz, Madrid, Spain.ORCID 0000-0002-9993-5249
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Fetal Growth RetardationInfant, Small for Gestational AgeAdultBiomarkersCohort StudiesFemaleGestational AgeHumansInfant, NewbornLogistic ModelsMalePlacenta Growth FactorPredictive Value of TestsPregnancyPregnancy Trimester, ThirdRetrospective StudiesBiomarkersPlacenta Growth Factorbirthweight percentileDopplerfetal growth restriction (FGR)PlGFprediction modelpregnancyscreeningsFlt-1small for gestational age (SGA)third-trimester ultrasound
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Prediction of Small for Gestational Age and Growth-Restricted Neonates at 35 to 36 Weeks of Gestation: A Multicenter Cohort Study. · full record | OpenQuestion